3V5-18866-39689
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 774 / TX
- Registered
- 2021-04-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-22
Registered in v-safe
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Eye pain — Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness · Be unable to workFree text: Eyes hurtMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-13
- 2021-05-20
- 2021-06-03
-
2022-07-12
Dose 3 — Pfizer-BioNTech
- 2022-07-13
- 2022-07-14
- 2022-07-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2022-07-12 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Eyes hurt
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Eye pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release